The Spanish factory produces miles of dexamethasone treatment, the only drug that has a determinant in the pandemic.
Katherine Trujillo Useche
Agencia Latina de Noticias Medicina y Salud Pública
The dexamethasone is a molecule formed by 22 carbon atoms, 29 hydrogen, one fluorine and five cents of oxygen along with the COVID-19 patient.
The doctor Ana Fernández Cruz spoke about the first oil of the pandemic, but many of them could not help but compare the number of contagions and deaths that are present in the world to cause coronavirus, which can be recorded as no treatment.
The team of Dra. Cruz del Hospital madrileño Puerta de Hierro Majadahonda, pioneered in investigating the efficacy of dexamethasone, an anti-inflammatory drug that was economical in his country. A large clinical trial coordinated by the University of Oxford in the United Kingdom in June demonstrated that the molecule reduced the risk of death from more severe patients. The authors of the study found that Podrían salvaged 650,000 lives during the year.
José Luís Barredo of 59 years, biologist, is one of the managers of the dexamethasone factory that has in Spain, the Crystal Pharma company, in Boecillo.
The vallisoletana plant produces 3,000 kilos of dexamethasone last year, 65% more than antandemias. If the three scenes are dedicated to COVID-19 nurses, it suffices for 50 million patients. The calculations of the University of Oxford show that in any case serious grievances made with dexamethasone prevent death.
Crystal Pharma which exports the dexametasona fábrica ingredients of pharmacacuticos, 90% of the production and more than 70 países, which contains the Barredo division. “We are sorry for our contribution in the face of the pandemic,” he said.
“The base of treatment of the COVID-19 grave, now the same, is the dexamethasone”, signaled the pharmacist Jesús Sierra, of the Spanish Society of Hospital Pharmacy (SEFH).
The results of the clinical trial of the University of Oxford, show that he treated 34 people to save a life in the group of patients who needed oxygen, but did not meet in a critical state. The patients who are in UCI alone have taken 8 serious illnesses to avoid death.
Dexamethasone is the best found in a year since the pandemic. The Oxford study, conducted in the first instance, shows that the mortality rate of mechanical ventilation in the UCI varies from 41% to 29% thanks to dexamethasone.
“Sigue has a very high mortality rate in COVID-19 hospitalized hospitals, including Sierra. The combination of dexamethasone with tocilizumab, a drug against rheumatoid arthritis reduces up to 50% the mortality of patients admitted to the UCI, according to the latest results from the Oxford study, this 50% is the maximum that has been followed now.